| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/10/2013 | EP2575886A1 Nanocarrier compositions with uncoupled adjuvant |
| 04/10/2013 | EP2575883A2 Treatment of inflammatory disorders |
| 04/10/2013 | EP2575876A1 Multivalent synthetic nanocarrier vaccines |
| 04/10/2013 | EP2575864A1 Trefoil factors (tff) for the treatment of chronic pulmonary diseases |
| 04/10/2013 | EP2575850A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1 |
| 04/10/2013 | EP2575839A2 Oral formulations for counteracting effects of aging |
| 04/10/2013 | EP2575829A1 Kit for the treatment of onychomycosis by nitric oxide |
| 04/10/2013 | EP2575821A2 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| 04/10/2013 | EP2575810A1 Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitor |
| 04/10/2013 | EP2575809A1 Compositions for treating helicobacter pylori infection |
| 04/10/2013 | EP2575800A1 Rhenium complexes and their pharmaceutical use. |
| 04/10/2013 | EP2575792A1 Biguanide compounds and its use for treating cancer |
| 04/10/2013 | EP2575774A1 Combination therapy methods for treating proliferative diseases |
| 04/10/2013 | EP2575773A2 Synthetic nanocarrier combination vaccines |
| 04/10/2013 | EP2575763A2 Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer |
| 04/10/2013 | EP2575757A1 Water soluble formulation comprising a combination of amlodipine and a statin |
| 04/10/2013 | EP2575474A1 Methods for increasing the production or activity of catalase |
| 04/10/2013 | EP2575458A1 Tocotrienol compositions |
| 04/10/2013 | CN103037863A Method for treating schizophrenia and related diseases |
| 04/10/2013 | CN103030140A Oxidized graphene modified by hyaluronic acid and preparation method and application of medicinal composition of oxidized graphene modified by hyaluronic acid |
| 04/10/2013 | CN103028118A Drug carriers, their synthesis, and methods of use thereof |
| 04/10/2013 | CN103027897A Method for preparing monodispersity hydrophobic drug nanoparticles by template method |
| 04/10/2013 | CN102105148B Therapeutic combination comprising an AURORA kinase inhibitor and antiproliferative agents |
| 04/10/2013 | CN102078621B Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 04/10/2013 | CN102058885B Combination therapy of lower urinary tract disorders with Alpha2Delta ligands and NSAIDs |
| 04/10/2013 | CN101664552B Stabilization of hypoxia inducible factor (HIF) alpha |
| 04/10/2013 | CN101636166B Progesterone for the prevention of spontaneous preterm birth |
| 04/10/2013 | CN101267807B Composition comprising a nsaid and paracetamol |
| 04/09/2013 | US8415456 Substituted IL-15 polypeptides |
| 04/09/2013 | US8415364 Method of preventing or treating glaucoma |
| 04/09/2013 | US8415317 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 04/09/2013 | US8414899 Vaccines comprising multimeric HSP60 peptide carriers |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414876 Methods of using IL-1 antagonists to treat autoinflammatory disease |
| 04/09/2013 | US8414768 Citrate-based dialysate chemical formulations |
| 04/09/2013 | CA2749172C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 04/09/2013 | CA2651604C Method for preparation of substantially amorphous telmisartan |
| 04/09/2013 | CA2601501C Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 04/09/2013 | CA2581927C Treatment or prevention of unscheduled bleeding in women on progestogen containing medication |
| 04/09/2013 | CA2536436C 2-amido-4-aryloxy-1-carbonyl pyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/09/2013 | CA2450777C Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 04/09/2013 | CA2399219C Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/09/2013 | CA2361658C T helper cell epitopes |
| 04/04/2013 | WO2013049300A1 Method of treating mucoepidermoid carcinoma |
| 04/04/2013 | WO2013049093A1 Combination therapy for chemoresistant cancers |
| 04/04/2013 | WO2013049045A1 Compositions and methods of treating gliomas |
| 04/04/2013 | WO2013045963A1 A pharmaceutical composition for the treatment of stem cells |
| 04/04/2013 | WO2013045891A1 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd) |
| 04/04/2013 | WO2013045538A1 Pharmaceutical preparation for treating nadh-caused diseases |
| 04/04/2013 | WO2013045068A1 Compositions comprising phytoestrogens receptor beta agonists and dietary fibres for chemopreventive treatment of sporadic adenomatous polyposis |
| 04/04/2013 | WO2013019620A3 Method of treating cancer using combination of braf inhibitor, mek inhibitor, and anti-ctla-4 antibody |
| 04/04/2013 | US20130085180 Oral bioavailable pentamidin prodrugs for treatment of diseases |
| 04/04/2013 | US20130085174 Acne treatment |
| 04/04/2013 | US20130085161 Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/04/2013 | US20130085159 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine |
| 04/04/2013 | US20130085158 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 04/04/2013 | US20130085155 Thiazolopyridine sirtuin modulating compounds |
| 04/04/2013 | US20130085144 Derivatives of azaindazole or diazaindazole type as medicament |
| 04/04/2013 | US20130085123 Organic compounds |
| 04/04/2013 | US20130085116 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof |
| 04/04/2013 | US20130085107 Treatments for Gastrointestinal Disorders |
| 04/04/2013 | US20130085100 New Uses of Oxytocin-Like Molecules and Related Methods |
| 04/04/2013 | US20130085097 Papillomavirus virus-like particle or capsomere formulation and its use as microbicide |
| 04/04/2013 | US20130085096 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/04/2013 | US20130084346 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 04/04/2013 | US20130084345 Indibulin therapy |
| 04/04/2013 | US20130084307 Vaccine composition containing synthetic adjuvant |
| 04/04/2013 | US20130084301 Cluster of Neutralizing Antibodies to Hepatitis C Virus |
| 04/04/2013 | US20130084300 Diagnosis and prevention of cancer cell invasion |
| 04/04/2013 | US20130084290 Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | US20130084264 Anti-tumor composition |
| 04/04/2013 | US20130084262 Repairing bruch's membrane with hydrogels |
| 04/04/2013 | US20130084242 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor |
| 04/04/2013 | CA2849903A1 Combination therapy for chemoresistant cancers |
| 04/04/2013 | CA2848065A1 Method of treating mucoepidermoid carcinoma |
| 04/04/2013 | CA2845677A1 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd) |
| 04/03/2013 | EP2574340A2 Combination comprising a pyrimidylaminobenzamide compound and a THR315LLEe kinase inhibitor |
| 04/03/2013 | EP2574339A1 Pharmaceutical preparation for treating NADH-related illnesses |
| 04/03/2013 | EP2574336A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/03/2013 | EP2574194A2 Macrocyclic compounds and methods of treatment |
| 04/03/2013 | CN1972676B Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN1526018B Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/03/2013 | CN103025758A IL-1 binding proteins |
| 04/03/2013 | CN103025325A Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy |
| 04/03/2013 | CN103012374A Piperizinylpiperidine derivatives as chemokine receptor antagonists |
| 04/03/2013 | CN103007288A Improved depot formulations |
| 04/03/2013 | CN103007284A Application of HMGCoA reductase inhibitor in preparation of medicine used for treating xerophthalmia |
| 04/03/2013 | CN103007283A Constructing method of aromatizing enzyme disorder rat depression model |
| 04/03/2013 | CN103007282A Eye mask based on combination of nitric oxide and Chinese medicinal materials |
| 04/03/2013 | CN103006782A Ficus auriculata extract and application thereof in preparation of medicine used for treating osteoporosis |
| 04/03/2013 | CN103006573A Method for preparing gelatin microballoon embolization agent |
| 04/03/2013 | CN103006565A Nano granular medicinal composition and preparation method thereof |
| 04/03/2013 | CN103006564A Thermally-stable sweet wormwood solid dispersion composition and preparation method thereof |
| 04/03/2013 | CN103006546A Preparation and application of carbon nano tube-containing thermo-sensitive type gel entrapping for indissolvable drug |
| 04/03/2013 | CN102406642B Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines |
| 04/03/2013 | CN102107008B DNA damage repair inhibitors for treatment of cancer |
| 04/03/2013 | CN101926773B Medicament-carrying lipoid particulates and preparation method thereof |